Transthyretin Amyloidosis: Update on the Clinical Spectrum, Pathogenesis, and Disease-Modifying Therapies

ATTR amyloidosis is caused by systemic deposition of transthyretin (TTR) and comprises ATTRwt (wt for wild-type) amyloidosis, ATTRv (v for variant) amyloidosis, and acquired ATTR amyloidosis after domino liver transplantation. ATTRwt amyloidosis has classically been regarded as cardiomyopathy found...

Descripción completa

Detalles Bibliográficos
Autores principales: Koike, Haruki, Katsuno, Masahisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500251/
https://www.ncbi.nlm.nih.gov/pubmed/32948978
http://dx.doi.org/10.1007/s40120-020-00210-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500251/
https://www.ncbi.nlm.nih.gov/pubmed/32948978
http://dx.doi.org/10.1007/s40120-020-00210-7

Ejemplares similares